AMICUS THERAPEUTICS INC
NASDAQ: FOLD (Amicus Therapeutics, Inc.)
最近更新时间: 2天之前, 5:37PM6.03
-0.14 (-2.27%)
| 前收盘价格 | 6.17 |
| 收盘价格 | 6.05 |
| 成交量 | 4,134,912 |
| 平均成交量 (3个月) | 4,380,277 |
| 市值 | 1,856,824,064 |
| 预期市盈率 (P/E Forward) | 49.02 |
| 价格/销量 (P/S) | 3.47 |
| 股市价格/股市净资产 (P/B) | 9.82 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | -5.41% |
| 营业利益率 (TTM) | -6.35% |
| 稀释每股收益 (EPS TTM) | -0.090 |
| 季度收入增长率 (YOY) | 13.40% |
| 总债务/股东权益 (D/E MRQ) | 229.11% |
| 流动比率 (MRQ) | 3.34 |
| 营业现金流 (OCF TTM) | 3.56 M |
| 杠杆自由现金流 (LFCF TTM) | 29.27 M |
| 资产报酬率 (ROA TTM) | 3.95% |
| 股东权益报酬率 (ROE TTM) | -18.12% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Amicus Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | 1.5 |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.60 |
|
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.75% |
| 机构持股比例 | 102.83% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Palo Alto Investors Lp | 31 Mar 2025 | 7,345,002 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 22.00 (UBS, 264.84%) | 购买 |
| 中 | 15.50 (157.05%) | |
| 低 | 9.00 (Goldman Sachs, 49.25%) | 保留 |
| 平均值 | 15.50 (157.05%) | |
| 总计 | 1 购买, 1 保留 | |
| 平均价格@调整类型 | 6.67 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Goldman Sachs | 02 May 2025 | 9.00 (49.25%) | 保留 | 6.67 |
| UBS | 02 May 2025 | 22.00 (264.84%) | 购买 | 6.67 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BLEIL LYNN DORSEY | 5.96 | - | 20,414 | 121,667 |
| KELLY MICHAEL AARON | 5.96 | - | 20,414 | 121,667 |
| MCGLYNN MARGARET G | 5.96 | - | 20,414 | 121,667 |
| RAAB MICHAEL | 5.96 | - | 20,414 | 121,667 |
| ROBERTS EIRY | 5.96 | - | 20,414 | 121,667 |
| SBLENDORIO GLENN | 5.96 | - | 20,414 | 121,667 |
| WHEELER CRAIG A | 5.96 | - | 20,414 | 121,667 |
| WHITMAN BURKE W | 5.96 | - | 20,414 | 121,667 |
| 累积净数量 | 163,312 | |||
| 累积净值 ($) | 973,340 | |||
| 累积平均购买 ($) | 5.96 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| WHITMAN BURKE W | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| WHEELER CRAIG A | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| BLEIL LYNN DORSEY | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| ROBERTS EIRY | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| KELLY MICHAEL AARON | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| SBLENDORIO GLENN | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| RAAB MICHAEL | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
| MCGLYNN MARGARET G | 董事 | 05 Jun 2025 | 获得 (+) | 20,414 | 5.96 | 121,667 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合